HPV type | HPVI (N = 496) | 6MPI (N = 281) | CIN1+ (N = 50) | CIN2+ (N = 29) | ||||
---|---|---|---|---|---|---|---|---|
n (%) | Incidence per 100 PY (95% CI) 1 | n (%) | Incidence per 100 PY (95% CI) 1 | n (%) | Incidence per 100 PY (95% CI) 1 | n (%) | Incidence per 100 PY (95% CI) 1 | |
All | 496 (50.5)2 | 27.08 (24.75-29.57) | 281 (28.6)2 | 13.29 (11.78-14.94) | 50 (5.1)2 | 1.87 (1.39-2.46) | 29 (3.0)2 | 1.07 (0.72-1.54) |
Oncogenic HPV types | ||||||||
16 | 90 (18.2) | 4.91 (3.95-6.04) | 58 (20.6) | 2.74 (2.08-3.55) | 22 (44.0) | 0.82 (0.52-1.24) | 17 (58.6) | 0.63 (0.37-1.01) |
18 | 50 (10.1) | 2.73 (2.03-3.60) | 23 (8.2) | 1.09 (0.69-1.63) | 3 (6.0) | 0.11 (0.02-0.33) | 2 (6.9) | 0.07 (0.01-0.27) |
31 | 32 (6.5) | 1.75 (1.20-2.47) | 19 (6.8) | 0.90 (0.54-1.40) | 6 (12.0) | 0.22 (0.08-0.49) | 2 (6.9) | 0.07 (0.01-0.27) |
33 | 21 (4.2) | 1.15 (0.71-1.75) | 10 (3.6) | 0.47 (0.23-0.87) | 4 (8.0) | 0.15 (0.04-0.38) | 3 (10.3) | 0.11 (0.02-0.32) |
35 | 9 (1.8) | 0.49 (0.22-0.93) | 3 (1.1) | 0.14 (0.03-0.41) | 1 (2.0) | 0.04 (0.00-0.21) | 0 | 0.00 (0.00-0.14) |
39 | 34 (6.9) | 1.86 (1.29-2.59) | 20 (7.1) | 0.95 (0.58-1.46) | 3 (6.0) | 0.11 (0.02-0.33) | 2 (6.9) | 0.07 (0.01-0.27) |
45 | 22 (4.4) | 1.20 (0.75-1.82) | 6 (2.1) | 0.28 (0.10-0.62) | 1 (2.0) | 0.04 (0.00-0.21) | 0 | 0.00 (0.00-0.14) |
51 | 109 (22.0) | 5.95 (4.89-7.18) | 57 (20.3) | 2.70 (2.04-3.49) | 7 (14.0) | 0.26 (0.11-0.54) | 4 (13.8) | 0.15 (0.04-0.38) |
52 | 61 (12.3) | 3.33 (2.55-4.28) | 35 (12.5) | 1.66 (1.15-2.30) | 4 (8.0) | 0.15 (0.04-0.38) | 2 (6.9) | 0.07 (0.01-0.27) |
56 | 44 (8.9) | 2.40 (1.75-3.23) | 19 (6.8) | 0.90 (0.54-1.40) | 5 (10.0) | 0.19 (0.06-0.44) | 3 (10.3) | 0.11 (0.02-0.32) |
58 | 22 (4.4) | 1.20 (0.75-1.82) | 14 (5.0) | 0.66 (0.36-1.11) | 7 (14.0) | 0.26 (0.11-0.54) | 2 (6.9) | 0.07 (0.01-0.27) |
59 | 26 (5.2) | 1.42 (0.93-2.08) | 1 (0.4) | 0.05 (0.00-0.26) | 0 | 0.00 (0.00-0.14) | 0 | 0.00 (0.00-0.14) |
66 | 46 (9.3) | 2.51 (1.84-3.35) | 24 (8.5) | 1.14 (0.73-1.69) | 4 (8.0) | 0.15 (0.04-0.38) | 1 (3.5) | 0.04 (0.00-0.21) |
68 | 37 (7.5) | 2.02 (1.42-2.78) | 17 (6.1) | 0.80 (0.47-1.29) | 4 (8.0) | 0.15 (0.04-0.38) | 3 (10.3) | 0.11 (0.02-0.32) |
At least 1 oncogenic type | 399 (80.4) | 21.79 (19.70-24.03) | 232 (82.6) | 10.97 (9.61-12.48) | 50 (100.0) | 1.87 (1.39-2.46) | 29 (100) | 1.07 (0.72-1.54) |
Non-oncogenic HPV types | ||||||||
6 | 74 (14.9) | 4.04 (3.17-5.07) | 21 (7.5) | 0.99 (0.61-1.52) | 3 (6.0) | 0.11 (0.02-0.33) | 1 (3.5) | 0.04 (0.00-0.21) |
11 | 9 (1.8) | 0.49 (0.22-0.93) | 1 (0.4) | 0.05 (0.00-0.26) | 2 (4.0) | 0.07 (0.01-0.27) | 0 | 0.00 (0.00-0.14) |
34 | 7 (1.4) | 0.38 (0.15-0.79) | 1 (0.4) | 0.05 (0.00-0.26) | 0 | 0.00 (0.00-0.14) | 0 | 0.00 (0.00-0.14) |
40 | 16 (3.2) | 0.87 (0.50-1.42) | 1 (0.4) | 0.05 (0.00-0.26) | 2 (4.0) | 0.07 (0.01-0.27) | 1 (3.5) | 0.04 (0.00-0.21) |
42 | 7 (1.4) | 0.38 (0.15-0.79) | 0 | 0.00 (0.00-0.17) | 0 | 0.00 (0.00-0.14) | 0 | 0.00 (0.00-0.14) |
43 | 27 (5.4) | 1.47 (0.97-2.14) | 3 (1.1) | 0.14 (0.03-0.41) | 0 | 0.00 (0.00-0.14) | 0 | 0.00 (0.00-0.14) |
44 | 4 (0.8) | 0.22 (0.06-0.56) | 1 (0.4) | 0.05 (0.00-0.26) | 0 | 0.00 (0.00-0.14) | 0 | 0.00 (0.00-0.14) |
53 | 56 (11.3) | 3.06 (2.31-3.97) | 28 (10.0) | 1.32 (0.88-1.91) | 3 (6.0) | 0.11 (0.02-0.33) | 2 (6.9) | 0.07 (0.01-0.27) |
54 | 16 (3.2) | 0.87 (0.50-1.42) | 8 (2.9) | 0.38 (0.16-0.75) | 3 (6.0) | 0.11 (0.02-0.33) | 2 (6.9) | 0.07 (0.01-0.27) |
70 | 6 (1.2) | 0.33 (0.12-0.71) | 6 (2.1) | 0.28 (0.10-0.62) | 1 (2.0) | 0.04 (0.00-0.21) | 0 | 0.00 (0.00-0.14) |
74 | 13 (2.6) | 0.71 (0.38-1.21) | 6 (2.1) | 0.28 (0.10-0.62) | 0 | 0.00 (0.00-0.14) | 0 | 0.00 (0.00-0.14) |
Only non-oncogenic type | 97 (19.6) | 5.30 (4.29-6.46) | 49 (17.4) | 2.32 (1.71-3.06) | 0 | 0.00 (0.00-0.14) | 0 | 0.00 (0.00-0.14) |